FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - SALIVARY GLANDS





Form # 785-1-030 

CLIN PATH  DEFINITIONS
     PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

T1 Tumor 2 cm or less in greatest dimension

  T1a Tumor 2 cm or less in greatest dimension

  T1b Tumor more than 2 cm in greatest dimension

T2 Tumor more than 2 cm but not more than 4 cm in greatest dimension

T3 Tumor more than 4 cm but not more than 6 cm in greatest dimension

T4   Tumor more than 6 cm in greatest dimension
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Regional lymph node metastasis

N2   Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greast dimension,

or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension,

or in bilateral or in contralateral lymph nodes, none more than 6 cm in greatest dimension

  N2a   Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension

  N2b   Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension

  N2c   Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension

N3   Metastasis in a lymph node more than 6 cm in greastest dimension
    DISTANT METASTASIS (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

CLIN PATH STAGE GROUPING

I T1a N0 M0

  T2a N0 M0

II T1b N0 M0

  T2b N0 M0

  T3a N0 M0

III T3b N0 M0
      T4a N0 M0
      Any T (Except T4b) N1 M0

IV T4b Any N M0
      Any T N2 M0
      Any T N3 M0
      Any T Any N M1

Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:
Patient Name: